PA
IHS icon

PharVision Advisers’s IHS Holding IHS Stock Holding History

PharVision Advisers’s Portfolio IHS Stock Details IHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,817
Closed -$222K – 362
2025
Q4 		$222K Buy
29,817
+1,515
+5% +$10.4K 0.11% 471
2025
Q3 		$193K Buy
+28,302
New +$189K 0.11% 524

Other funds holding IHS

WS
Wendel SE Paris $519M AUM 48.2% 1-Year Est. Return
Korea Investment Corp
Korea Investment Corp Seoul, South Korea $48.3B AUM 31.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QCI
Quaker Capital Investments Mount Lebanon, Pennsylvania $409M AUM 61.78% 1-Year Est. Return
PAM
PSquared Asset Management Zurich, Switzerland $287M AUM 58.62% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PharVision Advisers's IHS Position: Q1 2026 in Review

PharVision Advisers sold out of IHS Holding (IHS) in Q1 2026, closing a stake of 29,817 shares — an estimated $222K sold.

PharVision Advisers first reported a position in IHS in Q3 2025 and held it in 2 quarters. The position peaked at $222K in Q4 2025. 145 funds tracked by Wall St. Rank hold IHS as of Q1 2026.

  • PharVision Advisers reported no remaining IHS Holding position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 29,817 IHS Holding shares in Q1 2026, an estimated $222K.
  • PharVision Advisers first reported a position in IHS Holding in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's IHS Holding position peaked at $222K in Q4 2025.
  • 145 funds tracked by Wall St. Rank held IHS Holding as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.